Previous Article | Next Article 
Journal of Virology, January 2002, p. 525-531, Vol. 76, No. 2
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.76.2.525-531.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Paired Charge-to-Alanine Mutagenesis of Dengue Virus Type 4 NS5 Generates Mutants with Temperature-Sensitive, Host Range, and Mouse Attenuation Phenotypes
Kathryn A. Hanley,* Jay J. Lee, Joseph E. Blaney, Jr, Brian R. Murphy, and Stephen S. Whitehead
Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892
Received 27 July 2001/
Accepted 11 October 2001
Charge-to-alanine mutagenesis of dengue virus type 4 (DEN4) NS5 gene generated a collection of attenuating mutations for potential use in a recombinant live attenuated DEN vaccine. Codons for 80 contiguous pairs of charged amino acids in NS5 were individually mutagenized to create uncharged pairs of alanine residues, and 32 recombinant mutant viruses were recovered from the 80 full-length mutant DEN4 cDNA constructs. These mutant viruses were tested for temperature-sensitive (ts) replication in both Vero cells and HuH-7 human hepatoma cells. Of the 32 mutants, 13 were temperature sensitive (ts) in both cell lines, 11 were not ts in either cell line, and 8 exhibited a host range (tshr) phenotype. One tshr mutant was ts only in Vero cells, and seven were ts only in HuH-7 cells. Nineteen of the 32 mutants were 10-fold or more restricted in replication in the brains of suckling mice compared to that of wild-type DEN4, and three mutants were approximately 10,000-fold restricted in replication. The level of temperature sensitivity of replication in vitro did not correlate with attenuation in vivo. A virus bearing two pairs of charge-to-alanine mutations was constructed and demonstrated increased temperature sensitivity and attenuation relative to either parent virus. This large set of charge-to-alanine mutations specifying a wide range of attenuation for mouse brain should prove useful in fine-tuning recombinant live attenuated DEN vaccines.
* Corresponding author. Mailing address: LID, NIAID, NIH, Bldg. 7, Room 100, 7 Center Dr., Bethesda, MD 20892. Phone: (301) 402-7751. Fax: (301) 496-8312. E-mail:
khanley{at}niaid.nih.gov.
Journal of Virology, January 2002, p. 525-531, Vol. 76, No. 2
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.76.2.525-531.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Wright, P. F., Durbin, A. P., Whitehead, S. S., Ikizler, M. R., Henderson, S., Blaney, J. E., Thumar, B., Ankrah, S., Rock, M. T., McKinney, B. A., Murphy, B. R., Schmidt, A. C.
(2009). Phase 1 Trial of the Dengue Virus Type 4 Vaccine Candidate rDEN4{Delta}30-4995 in Healthy Adult Volunteers. Am J Trop Med Hyg
81: 834-841
[Abstract]
[Full Text]
-
McArthur, J. H., Durbin, A. P., Marron, J. A., Wanionek, K. A., Thumar, B., Pierro, D. J., Schmidt, A. C., Blaney, J. E. Jr, Murphy, B. R., Whitehead, S. S.
(2008). Phase I Clinical Evaluation of rDEN4{Delta}30-200,201: A Live Attenuated Dengue 4 Vaccine Candidate Designed for Decreased Hepatotoxicity. Am J Trop Med Hyg
79: 678-684
[Abstract]
[Full Text]
-
Kroschewski, H., Lim, S. P., Butcher, R. E., Yap, T. L., Lescar, J., Wright, P. J., Vasudevan, S. G., Davidson, A. D.
(2008). Mutagenesis of the Dengue Virus Type 2 NS5 Methyltransferase Domain. J. Biol. Chem.
283: 19410-19421
[Abstract]
[Full Text]
-
Sparks, J. S., Lu, X., Denison, M. R.
(2007). Genetic Analysis of Murine Hepatitis Virus nsp4 in Virus Replication. J. Virol.
81: 12554-12563
[Abstract]
[Full Text]
-
Romero, T. A., Tumban, E., Jun, J., Lott, W. B., Hanley, K. A.
(2006). Secondary structure of dengue virus type 4 3' untranslated region: impact of deletion and substitution mutations.. J. Gen. Virol.
87: 3291-3296
[Abstract]
[Full Text]
-
Uchil, P. D., Kumar, A. V. A., Satchidanandam, V.
(2006). Nuclear localization of flavivirus RNA synthesis in infected cells.. J. Virol.
80: 5451-5464
[Abstract]
[Full Text]
-
Rumyantsev, A. A., Murphy, B. R., Pletnev, A. G.
(2006). A Tick-Borne Langat Virus Mutant That Is Temperature Sensitive and Host Range Restricted in Neuroblastoma Cells and Lacks Neuroinvasiveness for Immunodeficient Mice. J. Virol.
80: 1427-1439
[Abstract]
[Full Text]
-
Blaney, J. E. Jr., Matro, J. M., Murphy, B. R., Whitehead, S. S.
(2005). Recombinant, Live-Attenuated Tetravalent Dengue Virus Vaccine Formulations Induce a Balanced, Broad, and Protective Neutralizing Antibody Response against Each of the Four Serotypes in Rhesus Monkeys. J. Virol.
79: 5516-5528
[Abstract]
[Full Text]
-
BLANEY, J. E. JR., HANSON, C. T., FIRESTONE, C.-Y., HANLEY, K. A., MURPHY, B. R., WHITEHEAD, S. S.
(2004). GENETICALLY MODIFIED, LIVE ATTENUATED DENGUE VIRUS TYPE 3 VACCINE CANDIDATES. Am J Trop Med Hyg
71: 811-821
[Abstract]
[Full Text]
-
Brooks, A. J., Johansson, M., John, A. V., Xu, Y., Jans, D. A., Vasudevan, S. G.
(2002). The Interdomain Region of Dengue NS5 Protein That Binds to the Viral Helicase NS3 Contains Independently Functional Importin beta 1 and Importin alpha /beta -Recognized Nuclear Localization Signals. J. Biol. Chem.
277: 36399-36407
[Abstract]
[Full Text]